Biogen Exercises Option to Increase Ownership in Samsung Bioepis
June 28, 2018 16:06 ET
|
Biogen Inc.
Biogen will pay Samsung BioLogics approximately $700 million to increase its ownership in Samsung Bioepis to approximately 49.9%Transaction expected to close in the second half of 2018 CAMBRIDGE,...
Biogen to Report Second Quarter 2018 Financial Results on July 24, 2018
June 25, 2018 16:01 ET
|
Biogen Inc.
CAMBRIDGE, Mass., June 25, 2018 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq:BIIB) today announced it will report second quarter 2018 financial results on Tuesday, July 24, 2018, before the financial...
Biogen to Host Investor Webcast on Its Efforts Targeting Stroke on June 28, 2018
June 19, 2018 16:01 ET
|
Biogen Inc.
CAMBRIDGE, Mass., June 19, 2018 (GLOBE NEWSWIRE) -- Biogen (Nasdaq:BIIB) today announced it will host a live webcast providing an overview of its efforts targeting acute ischemic stroke on Thursday,...
Biogen Foundation Selects Grantees to Receive $10 Million Investment for STEM Education
June 18, 2018 16:30 ET
|
Biogen Inc.
CAMBRIDGE, Mass., June 18, 2018 (GLOBE NEWSWIRE) -- The Biogen Foundation today announced the six nonprofits that will share a previously-announced four-year, $10 million grant to drive the...
Biogen Enhances Commitment to SMA Research with Data Presented at Annual SMA Conference
June 13, 2018 07:30 ET
|
Biogen Inc.
Research includes clinical trial data across broad SMA patient populations, expanding scientific understanding of SMA and SPINRAZA® (nusinersen) Study presented examines neurofilament (pNF-H) as a...
Biogen Enters Exclusive Option Agreement to Acquire TMS’ Phase 2 Asset for Acute Stroke
June 07, 2018 07:30 ET
|
Biogen Inc.
TMS-007 is designed to restore blood flow following acute stroke, with an extended treatment window versus current standard of careBiogen to pay $4 million upfront and $18 million upon exercise of the...
Biogen Appoints Daniel Karp as EVP, Corporate Development
May 31, 2018 07:30 ET
|
Biogen Inc.
Seasoned executive brings strong track record of success leading licensing and M&A transactions CAMBRIDGE, Mass., May 31, 2018 (GLOBE NEWSWIRE) -- Biogen (Nasdaq:BIIB) announced today the...